CELCUITY INC. Operating Lease Liability
CELCUITY INC. (CELC) had Operating Lease Liability of $54.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-13
- 2025-12-31: Operating Lease, Liability $54.00K.
- 2025-11-30: Operating Lease, Liability $1.10M.
- 2024-12-31: Operating Lease, Liability $225.92K.
- 2023-12-31: Operating Lease, Liability $410.87K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2025-12-31 | $54.00K 10-K · filed 2026-03-26 | |
| 2025-11-30 | $1.10M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $225.92K 10-K · filed 2025-03-31 | |
| 2023-12-31 | $410.87K 10-K · filed 2024-03-27 | |
| 2022-12-31 | $252.75K 10-K · filed 2023-03-23 | |
| 2022-06-30 | $156.77K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $204.59K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $251.63K 10-K · filed 2022-03-23 | |
| 2021-09-30 | $299.37K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $153.68K 10-Q · filed 2021-08-11 | |
| 2020-09-30 | $189.40K 10-Q · filed 2020-11-09 | |
| 2020-03-31 | $176.60K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $178.47K 10-Q · filed 2020-11-09 | $236.26K 10-K · filed 2020-03-13 |
| 2019-09-30 | $266.50K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $327.82K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $358.90K 10-Q · filed 2019-05-07 | |
| 2019-01-01 | $404.93K 10-Q · filed 2019-08-08 | |
| 2018-12-31 | $404.93K 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |